United States · FDA National Drug Code directory

spironolactone

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68382-660_79b8df9c-5a73-432e-bd16-bbbecd9e2046
Product NDC
68382-660
Form
TABLET, FILM COATED
Composition / generic term
spironolactone
Labeler
Zydus Pharmaceuticals (USA) Inc.
Marketing category
ANDA
Marketing start / end (source format)
20180815
Source listing expiry
20261231

Source-listed ingredients

  • SPIRONOLACTONE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, FILM COATED in 1 BOTTLE (68382-660-01) · 68382-660-01
  • 500 TABLET, FILM COATED in 1 BOTTLE (68382-660-05) · 68382-660-05
  • 30 TABLET, FILM COATED in 1 BOTTLE (68382-660-06) · 68382-660-06
  • 1000 TABLET, FILM COATED in 1 BOTTLE (68382-660-10) · 68382-660-10
  • 90 TABLET, FILM COATED in 1 BOTTLE (68382-660-16) · 68382-660-16
  • 10 BLISTER PACK in 1 CARTON (68382-660-30) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 68382-660-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →